Skip to main content

Table 3 Crude and adjusted odds ratios (OR) of T2D occurrence based on logistic regression modelling among patients with SCZ

From: Combination therapy as a potential risk factor for the development of type 2 diabetes in patients with schizophrenia: the GOMAP study

Variables

Crudea

Adjustedc

OR (95%CI)

Corrected p-value

OR (95%CI)

p-value

Sex

(Reference group = Female)

1.38 (1.06–1.81)

0.063

1.42 (1.08–1.85)a

0.0112

Psychiatric Medication

(Reference group = FGA)

 SGA

1.27 (0.84–1.93)

0.595

1.27 (0.84–1.93)

0.259

 2-Drug Combination

0.96 (0.69–1.33)

0.937

0.98 (0.71–1.35)

0.885

 ≥3-Drug Combination

1.75 (1.19–2.59)b

0.035

1.81 (1.22–2.69)b

0.003

 Number of hospitalizations

1.00 (0.96–1.03)

0.937

0.99 (0.96–1.03)

0.749

 Duration of SCZ

1.00 (0.98–1.02)

0.960

1.00 (0.98–1.02)

0.975

 Outdoor Physical activity in last week: (reference group = No)

0.62 (0.16–2.38)

0.858

0.71 (0.19–2.66)

0.613

  1. aadjusted for age and BMI
  2. bSignificant predictor of T2D among SCZ patients
  3. cAdjusted for age, BMI, sex, duration of SCZ and number of hospitalizations